Subspecies: clade-681 (HMT-0681) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.12 | 0.11 | 0.07 | 0.13 | 2.61 | 10.41 | 0.71 | 0.69 | 0.92 | 3.55 | 0.11 | 0.04 | 0.01 | 1.43 | 0 | 0.09 | 0.01 | 0.01 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.01 | 0.01 | 0 | 0 | 0.08 | 10.41 | 0.16 | 0.27 | 0.15 | 0.50 | 0.01 | 0 | 0 | 1.43 | 0 | 0 | 0 | 0 |
| 90thp | 0.31 | 0.19 | 0.19 | 0.39 | 7.69 | 10.41 | 1.48 | 1.33 | 2.75 | 8.34 | 0.20 | 0.10 | 0.04 | 1.43 | 0 | 0.21 | 0.02 | 0 |
| Stdev | 0.21 | 0.30 | 0.16 | 0.20 | 4.35 | 0 | 0.68 | 0.50 | 0.97 | 3.68 | 0.23 | 0.07 | 0.01 | 0 | 0 | 0.23 | 0.03 | 0.18 |
| Prev(%) | 33.33 | 31.90 | 12.50 | 53.33 | 81.73 | 100.00 | 62.50 | 100.00 | 90.91 | 99.53 | 3.08 | 13.04 | 6.67 | 0 | 0 | 12.50 | 0 | 0.80 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.05 | 0.07 | 0.47 | 2.26 | 3.62 | 1.50 | 2.39 | 1.80 | 4.89 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.07 | 0.69 | 0.07 | 0.14 | 0.13 | 0.69 | 0 |
| 90thp | 0.11 | 0.13 | 1.45 | 5.95 | 6.91 | 3.76 | 6.54 | 4.32 | 12.79 | 0 |
| Stdev | 0.13 | 0.21 | 1.08 | 3.34 | 3.47 | 2.70 | 2.52 | 2.32 | 5.06 | 0.01 |
| Prev(%) | 50.65 | 48.05 | 64.94 | 94.81 | 98.70 | 94.81 | 94.81 | 97.40 | 100.00 | 3.90 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to R. dentocariosa and R. mucilaginosa were assigned half to each taxon.
Reads equally close to R. dentocariosa and R. mucilaginosa were assigned half to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.47 | 0.88 | 0.09 | 0.52 | 0.52 | 0.21 | 0.25 | 0.20 | 0.66 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.46 | 2.42 | 0.15 | 1.37 | 1.42 | 0.50 | 0.66 | 0.51 | 1.76 | 0 |
| Stdev | 0.97 | 1.86 | 0.33 | 1.17 | 0.77 | 0.35 | 0.36 | 0.32 | 1.04 | 0 |
| Prev(%) | 68.92 | 74.32 | 39.87 | 71.62 | 80.41 | 74.32 | 70.95 | 73.65 | 80.41 | 1.40 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.11 | 0.06 | 0.56 | 3.67 | 4.25 | 1.40 | 1.72 | 1.41 | 4.07 | 0.12 | 0.05 | 0.06 | 0.25 | 0.27 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.08 | 0.46 | 0 | 0.10 | 0.07 | 0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.25 | 0.16 | 1.85 | 11.02 | 8.34 | 3.56 | 4.04 | 3.54 | 10.53 | 0.20 | 0.12 | 0.07 | 0.73 | 0.67 | 0 | 0 | 0 | 0 |
| Stdev | 0.32 | 0.14 | 1.26 | 6.23 | 4.98 | 2.36 | 1.99 | 2.00 | 5.03 | 0.52 | 0.22 | 0.54 | 0.59 | 0.70 | 0 | 0 | 0 | 0 |
| Prev(%) | 56.95 | 58.28 | 77.62 | 92.47 | 97.31 | 87.69 | 96.43 | 94.00 | 96.13 | 50.00 | 35.34 | 32.30 | 51.72 | 51.61 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.05 | 0.06 | 0.64 | 2.78 | 3.29 | 0.79 | 1.21 | 0.99 | 2.85 | 0.10 | 0.13 | 0.13 | 0.21 | 0.32 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.03 | 0.36 | 0.03 | 0.01 | 0.04 | 0.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.10 | 1.25 | 9.06 | 8.45 | 1.66 | 3.00 | 2.51 | 6.84 | 0.15 | 0.19 | 0.12 | 0.48 | 0.48 | 0 | 0 | 0 | 0 |
| Stdev | 0.20 | 0.27 | 2.60 | 5.25 | 3.78 | 1.55 | 1.93 | 1.70 | 4.20 | 0.34 | 0.59 | 0.75 | 0.76 | 1.07 | 0 | 0 | 0 | 0 |
| Prev(%) | 33.58 | 35.85 | 54.81 | 90.57 | 98.47 | 91.37 | 90.97 | 94.89 | 98.78 | 43.30 | 28.98 | 29.32 | 46.90 | 45.33 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.12 | 0.08 | 0.48 | 2.17 | 3.29 | 2.74 | 0.93 | 0.79 | 1.57 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.04 | 0.25 | 0.22 | 0.07 | 0.04 | 0.01 | 0 |
| 90thp | 0.08 | 0.13 | 0.72 | 3.99 | 8.15 | 7.21 | 2.13 | 1.56 | 4.21 | 0 |
| Stdev | 0.52 | 0.22 | 1.38 | 4.60 | 5.62 | 3.06 | 0.90 | 1.31 | 2.14 | 0 |
| Prev(%) | 82.43 | 88.23 | 90.70 | 100.00 | 100.00 | 100.00 | 100.00 | 96.77 | 97.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes

